Topic

Blue Cross Blue Shield (BCBS Association)

A collection of 1330 issues

How to Get Kesimpta (Ofatumumab) Covered by Blue Cross Blue Shield in Virginia: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Kesimpta Covered by BCBS Virginia Anthem Blue Cross Blue Shield Virginia classifies Kesimpta (ofatumumab) as a non-preferred specialty drug requiring prior authorization and step therapy. To get covered, you need: (1) documented relapsing MS diagnosis with recent activity, (2) failure of at least 2 preferred first-line DMTs,

Getting Bavencio (Avelumab) Covered by Blue Cross Blue Shield in Washington: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Bavencio Covered by Blue Cross Blue Shield in Washington Bavencio (avelumab) requires prior authorization from Blue Cross Blue Shield plans in Washington for FDA-approved uses—metastatic Merkel cell carcinoma and maintenance urothelial carcinoma. Submit PA requests via provider portal or fax with diagnosis codes, staging, prior platinum

Get Amondys 45 (Casimersen) Covered by Blue Cross Blue Shield California: Decision Tree & Appeal Guide 2025

Quick Answer: Do You Qualify for Amondys 45 Coverage? Yes, if you meet Blue Shield of California's criteria: confirmed DMD with exon 45 mutation, prescribed by a neurologist/neuromuscular specialist, and (starting August 2025) ambulatory with 6-minute walk test ≥300 meters. Submit prior authorization via Provider Connection portal

Myths vs. Facts: Getting Emflaza (deflazacort) Covered by Blue Cross Blue Shield in Georgia

Answer Box: Getting Emflaza (deflazacort) Covered by BCBS Georgia Blue Cross Blue Shield of Georgia requires prior authorization for Emflaza (deflazacort) in patients ≥2 years with confirmed Duchenne muscular dystrophy. Key requirements include genetic DMD confirmation, elevated creatinine kinase levels (≥10x normal), and often a trial of generic prednisone/prednisolone

How to Get Eylea and Lucentis Covered by Blue Cross Blue Shield in New Jersey: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Eylea/Lucentis Covered by Blue Cross Blue Shield in New Jersey Blue Cross Blue Shield of New Jersey requires prior authorization for Eylea (aflibercept) and Lucentis (ranibizumab) under the medical benefit, with step therapy typically requiring bevacizumab (Avastin) first. Submit requests through the Horizon Blue Cross Blue

Myths vs. Facts: Getting Eylea and Lucentis Covered by Blue Cross Blue Shield in New York (Complete Appeals Guide)

Answer Box: Getting Eylea/Lucentis Covered by BCBS in New York Blue Cross Blue Shield of New York requires prior authorization for Eylea (aflibercept) and Lucentis (ranibizumab) with step therapy requiring bevacizumab (Avastin) trial first. Key steps: 1) Verify your specific BCBS plan's formulary and PA requirements via

How to Get Takhzyro (lanadelumab-flyo) Covered by Blue Cross Blue Shield in Georgia: Complete PA Guide and Appeal Process

Answer Box: Getting Takhzyro Covered by BCBS Georgia Takhzyro (lanadelumab-flyo) requires prior authorization (PA) on Blue Cross Blue Shield of Georgia (Anthem BCBSGA) formularies with quantity limits typically allowing 2 units per fill. To get coverage: (1) Confirm your HAE Type I/II diagnosis with C4 and C1-INH lab results,

How to Renew Opdivo (Nivolumab) Coverage with Blue Cross Blue Shield in California: 2025 Requirements & Timeline

Answer Box: Renewing Opdivo Coverage in California To renew Opdivo (nivolumab) with Blue Cross Blue Shield in California, submit your renewal request 30-45 days before your current authorization expires. You'll need updated imaging showing stable disease or response, recent lab work (liver function, thyroid, creatinine), and a letter

How to Get Hetlioz LQ (Tasimelteon Oral Suspension) Covered by Blue Cross Blue Shield in Pennsylvania: Complete Guide with Forms and Appeals

Answer Box: Getting Hetlioz LQ Covered in Pennsylvania Blue Cross Blue Shield Pennsylvania plans (Highmark and Independence Blue Cross) require prior authorization for Hetlioz LQ in children ages 3-15 with Smith-Magenis syndrome. The fastest path: (1) Get genetic testing confirming SMS diagnosis, (2) Document 6+ months of failed melatonin therapy,

How to Get Orladeyo (Berotralstat) Covered by Blue Cross Blue Shield in Florida: Complete Appeals Guide with Forms and Timelines

Answer Box: Getting Orladeyo Covered by Florida Blue Cross Blue Shield Orladeyo (berotralstat) requires prior authorization from Florida Blue Cross Blue Shield as a Tier 4 specialty drug with a $150 copay after deductible. To get coverage, you need: (1) confirmed HAE diagnosis with C1-INH testing, (2) documented attack frequency